1. Home >
  2. M&A >
  3. Merger >
  4. Canada >
  5. Bausch Health Acquires Biovail

M&A Deal Summary

Bausch Health Acquires Biovail

On June 21, 2010, Bausch Health acquired life science company Biovail

Acquisition Highlights
  • This is Bausch Health’s 6th transaction in the Life Science sector.
  • This is Bausch Health’s 2nd transaction in Canada.
  • This is Bausch Health’s 1st transaction in Quebec.

M&A Deal Summary
Date 2010-06-21
Target Biovail
Sector Life Science
Buyer(s) Bausch Health
Deal Type Merger
Advisor(s) Morgan Stanley (Financial)
Cravath, Swaine & Moore
Blake, Cassels & Graydon (Legal)

Target

Biovail

Quebec, Canada
Biovail Corp. is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products. The Company is focused on the development and commercialization of medicines that address unmet medical needs in niche specialty central nervous system (CNS) markets.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Bausch Health

Laval, Quebec, Canada
Category Company
Sector Life Science
Employees20,270
Revenue 9.6B USD (2024)
DESCRIPTION

Bausch Health is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology, and branded generics. Bausch Health is based in Laval, Quebec.

DEAL STATS #
Overall 7 of 36
Sector: Life Science M&A 6 of 22
Type: Merger M&A Deals 1 of 1
State: Quebec M&A 1 of 1
Country: Canada M&A 2 of 3
Year: 2010 M&A 3 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-05-28 Aton Pharma

Lawrenceville, New Jersey, United States

Aton Pharma, Inc. is a specialty pharmaceutical company providing unique medicines to patients around the world.With 11 products on the market, 8 in the pipeline, and sales in over 30 countries, we are a global leader in providing medically essential treatments for serious and potentially life-threatening medical conditions. Our products address 2 areas — ophthalmic and orphan drug (rare disease) markets.

Buy $318M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-10-29 Hamilton Pharmaceutical - Sun Care and Skin Therapy Brands

Australia

Hamilton Pharmaceutical - Sun Care and Skin Therapy Brands comprises brands that include skin care products. The products include face sunscreens and skin therapy moisturizers and other treatment products.

Buy -
Mergr

Solution for

Product

Company

Legal